Market Tracker

01/23 11:01pm ET

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

0.417
Data as of Jan 23
 +0.017 / +4.25%
Today’s Change
0.33
Today|||52-Week Range
6.64
+4.25%
Year-to-Date

Today’s Trading

Previous close0.40
Today’s open0.39
Day’s range0.39 - 0.42
Volume138,028
Average volume (3 months)824,189
Market cap$14.9M
Dividend yield--
Data as of 4:00pm ET, 01/23/2015

Growth & Valuation

Earnings growth (last year)+39.13%
Earnings growth (this year)-14.29%
Earnings growth (next 5 years)--
Revenue growth (last year)+9.32%
P/E ratioNM
Price/Sales61.71
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ABIOARCA Biopharma Inc-0.01-1.41%
RGDXResponse Genetics In...-0.01-2.01%
KBIOKaloBios Pharmaceuti...+0.01+1.37%
CBLICleveland Biolabs In...+0.02+8.23%
Data as of 4:00pm ET, 01/23/2015

Financials

Next reporting dateMarch 13, 2015
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$3.4M
Annual profit (last year)-$4.9M
Net profit margin-146.13%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
André Monette
Corporate headquarters
Saint-Laurent, Quebec

Forecasts